Early strategic decisions
Build the evidence before narrowing the options.
For Search & Evaluate, portfolio strategy, corporate strategy, and investment teams.
For biopharma portfolio, strategy, and intelligence teams.
Complete strategic deliverables without months of manual evidence work.
Epistemic automates the evidence gathering and analysis behind competitive landscapes, target product profiles, conference intelligence, and related strategic work. Life-science experts review the evidence and deliver the finished analysis through dashboards, reports, and executive decks.
Scientist-delivered Traceable to sources Managed refresh available
Illustrative strategic deliverable
Decision context
Which programs change the portfolio priority?
Clinical trials
Congress abstracts
Regulatory sources
Portfolio implication
Evidence changes the priority—not just the
summary.
Program A moves to active monitoring; Program B requires an evidence-gap review.
Evidence register
Every conclusion remains traceable.
Evidence current through the agreed review cycle
The decision problem
Your team should not have to narrow the field before the evidence is broad enough.
Every additional asset, indication, competitor, or scenario can trigger months of fragmented research. Lean teams investigate fewer possibilities than the decision warrants—then receive a static deliverable that begins aging immediately.
Established CI programs
Maintain and expand work that already matters.
For competitive-intelligence and commercial-strategy teams that need current, reusable analysis.
What clients can buy today
The finished analysis is the deliverable.
Start with the strategic analysis you need. Receive it through the combination of formats that fits your workflow—and be as hands-on or hands-off as you choose.
Interactive dashboard
Detailed report
Executive deck
Structured output
Competitive and portfolio intelligence
Understand competitors, assets, clinical programs, catalysts, evidence gaps, and the implications for your portfolio.
Landscapes · asset profiles · trial matrices · strategic implications
Strategic deliverable
Competitive landscape
Strategic implications · evidence
register
View deliverables
Target product profiles
Define differentiation using connected clinical, competitive, regulatory, and market evidence.
Structured TPPs · benchmarks · positioning · strategic options
Strategic deliverable
Structured TPP
Evidence appendix · strategic options
View deliverables
Conference and evidence intelligence
Turn high-volume scientific and medical information into the signals, summaries, and actions that matter.
Readiness materials · executive summaries · evidence updates · implications
Strategic deliverable
Readiness deck
Evidence register · executive summary
View deliverables
Today and where we are going
Start with the strategic deliverable you need today.
Available today
Scientist-delivered strategic deliverables
The work can be refreshed on an agreed cadence as the evidence and competitive landscape change.
- Dashboards, reports, decks, and structured outputs
- Evidence reviewed by life-science experts
- Managed updates on an agreed cadence
Building toward
One connected intelligence platform
Epistemic is building the connected intelligence platform that will use the evidence behind each answer, make subsequent strategic questions faster to address, and make more possibilities practical to explore.
- Gather evidence once
- Connect it across strategic deliverables
- Explore far more hypotheses
The ambition: stop starting every strategic question from scratch—and expand the possibilities your team can evaluate before committing capital.
Selected engagements
Work that expands because it keeps proving useful.
Three examples of repeatable work moving beyond the first question or deliverable.
Top-20 pharma · Global RWE
Scale
30+
conferences supported each year
Conference intelligence became repeatable
Automated extraction, classification, and thematic analysis now support repeatable readiness work across therapeutic areas.
Strategic deliverable Readiness packs and evidence updates
Top-20 pharma · Strategic analytics
Documented delivery
Months → days
Then expanded from an initial TPP pilot
Target product profiles became an integrated workflow
Complete structured TPPs replaced a slow, inconsistent manual process and expanded beyond the initial engagement.
Strategic deliverable Structured TPPs and strategic options
Mid-size pharma · Oncology
Expansion
Portfolio-wide
Expanded from one oncology indication
A competitive landscape grew into a broader program
The work expanded into TPPs, conference intelligence, target identification, and portfolio-level trend analysis.
Strategic deliverable Landscapes and portfolio analysis
“Days, not months” reflects a documented target product profile engagement. Delivery timing depends on scope, evidence availability, and review requirements.